125 related articles for article (PubMed ID: 25984844)
1. Metachronous hormonal syndromes in patients with pancreatic neuroendocrine tumors: a case-series study.
de Mestier L; Hentic O; Cros J; Walter T; Roquin G; Brixi H; Lombard-Bohas C; Hammel P; Diebold MD; Couvelard A; Ruszniewski P; Cadiot G
Ann Intern Med; 2015 May; 162(10):682-9. PubMed ID: 25984844
[TBL] [Abstract][Full Text] [Related]
2. Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients.
Qiu W; Christakis I; Silva A; Bassett RL; Cao L; Meng QH; Gardner Grubbs E; Zhao H; Yao JC; Lee JE; Perrier ND
Clin Endocrinol (Oxf); 2016 Sep; 85(3):400-7. PubMed ID: 27256431
[TBL] [Abstract][Full Text] [Related]
3. Multiple and Secondary Hormone Secretion in Patients With Metastatic Pancreatic Neuroendocrine Tumours.
Crona J; Norlén O; Antonodimitrakis P; Welin S; Stålberg P; Eriksson B
J Clin Endocrinol Metab; 2016 Feb; 101(2):445-52. PubMed ID: 26672633
[TBL] [Abstract][Full Text] [Related]
4. Different Hormonal Expression Patterns Between Primary Pancreatic Neuroendocrine Tumors and Metastatic Sites.
Kimura H; Ohtsuka T; Fujimoto T; Date K; Matsunaga T; Cases AI; Abe A; Mizuuchi Y; Miyasaka Y; Ito T; Oda Y; Nakamura M; Tanaka M
Pancreas; 2016 Aug; 45(7):947-52. PubMed ID: 26684862
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic neuroendocrine tumors.
Batcher E; Madaj P; Gianoukakis AG
Endocr Res; 2011; 36(1):35-43. PubMed ID: 21226566
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.
Sugimoto M; Takagi T; Hikichi T; Suzuki R; Watanabe K; Nakamura J; Kikuchi H; Konno N; Waragai Y; Asama H; Takasumi M; Watanabe H; Obara K; Ohira H
World J Gastroenterol; 2015 Jul; 21(26):8118-24. PubMed ID: 26185384
[TBL] [Abstract][Full Text] [Related]
7. Fine-needle aspiration biopsy of pancreatic neuroendocrine tumors: Correlation between Ki-67 index in cytological samples and clinical behavior.
Díaz Del Arco C; Esteban López-Jamar JM; Ortega Medina L; Díaz Pérez JÁ; Fernández Aceñero MJ
Diagn Cytopathol; 2017 Jan; 45(1):29-35. PubMed ID: 27863178
[TBL] [Abstract][Full Text] [Related]
8. Comparison of functional and nonfunctional neuroendocrine tumors in the pancreas and peripancreatic region.
Wang SE; Su CH; Kuo YJ; Shyr YM; Li AF; Chen TH; Wu CW; Lee CH
Pancreas; 2011 Mar; 40(2):253-9. PubMed ID: 20966805
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors.
Hasegawa T; Yamao K; Hijioka S; Bhatia V; Mizuno N; Hara K; Imaoka H; Niwa Y; Tajika M; Kondo S; Tanaka T; Shimizu Y; Kinoshita T; Kohsaki T; Nishimori I; Iwasaki S; Saibara T; Hosoda W; Yatabe Y
Endoscopy; 2014 Jan; 46(1):32-8. PubMed ID: 24218309
[TBL] [Abstract][Full Text] [Related]
10. Primary endocrine-secreting pancreatic tumors.
Macaron C
Am Fam Physician; 1980 Apr; 21(4):94-8. PubMed ID: 6103668
[TBL] [Abstract][Full Text] [Related]
11. Mixed endocrine pancreatic tumors producing several peptide hormones.
Larsson LI; Grimelius L; Håkanson R; Rehfeld JF; Stadil F; Holst J; Angervall L; Sundler F
Am J Pathol; 1975 May; 79(2):271-84. PubMed ID: 167586
[TBL] [Abstract][Full Text] [Related]
12. Molecular alterations in sporadic pancreatic neuroendocrine microadenomas.
Hadano A; Hirabayashi K; Yamada M; Kawanishi A; Takanashi Y; Kawaguchi Y; Nakagohri T; Nakamura N; Mine T
Pancreatology; 2016; 16(3):411-5. PubMed ID: 26905832
[TBL] [Abstract][Full Text] [Related]
13. Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place.
de Mestier L; Gaujoux S; Cros J; Hentic O; Vullierme MP; Couvelard A; Cadiot G; Sauvanet A; Ruszniewski P; Richard S; Hammel P
Ann Surg; 2015 Aug; 262(2):384-8. PubMed ID: 25185468
[TBL] [Abstract][Full Text] [Related]
14. [Presence of hormonal polypeptides in the pure pancreatic secretion in man under stimulation by cerulein and secretin].
Escourrou J; Pradayrol L; Chayvialle JA; Fagot-Revurat P; Pudebat M; Ribet A
Gastroenterol Clin Biol; 1985 Nov; 9(11):782-6. PubMed ID: 2867946
[TBL] [Abstract][Full Text] [Related]
15. Everolimus Effect on Gastrin and Glucagon in Pancreatic Neuroendocrine Tumors.
Pavel ME; Chen D; He W; Cushman S; Voi M; de Vries EGE; Baudin E; Yao JC
Pancreas; 2017 Jul; 46(6):751-757. PubMed ID: 28609362
[TBL] [Abstract][Full Text] [Related]
16. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic apudomas.
Bloom SR; Polak JM; Welbourn RB
World J Surg; 1979 Sep; 3(5):587-95. PubMed ID: 516776
[TBL] [Abstract][Full Text] [Related]
18. Is the 2-cm size cutoff relevant for small nonfunctioning pancreatic neuroendocrine tumors: A French multicenter study.
Regenet N; Carrere N; Boulanger G; de Calan L; Humeau M; Arnault V; Kraimps JL; Mathonnet M; Pessaux P; Donatini G; Venara A; Christou N; Bachelier P; Hamy A; Mirallié E
Surgery; 2016 Mar; 159(3):901-7. PubMed ID: 26590096
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Tumor Markers for Predicting Disease-Free Survival in Surgically Resected Pancreatic Neuroendocrine Tumors.
Zhou B; Fang B; Yan S; Wang W
Clin Lab; 2017 Jul; 63(7):1251-1259. PubMed ID: 28792692
[TBL] [Abstract][Full Text] [Related]
20. Clinically Significant Differences in Ki-67 Proliferation Index Between Primary and Metastases in Resected Pancreatic Neuroendocrine Tumors.
Richards-Taylor S; Tilley C; Jaynes E; Hu H; Armstrong T; Pearce NW; Plant R; Cave J
Pancreas; 2017; 46(10):1354-1358. PubMed ID: 28984786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]